NM_000212.3(ITGB3):c.303A>G (p.Gly101=) AND ITGB3-related disorder

Germline classification:: Likely benign (1 submission)
Last evaluated:: May 26, 2023
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003919292.2

Allele description [Variation Report for NM_000212.3(ITGB3):c.303A>G (p.Gly101=)]

NM_000212.3(ITGB3):c.303A>G (p.Gly101=)

Gene:

ITGB3:integrin subunit beta 3 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

17q21.32

Genomic location:

Preferred name:

NM_000212.3(ITGB3):c.303A>G (p.Gly101=)

HGVS:

NC_000017.11:g.47283491A>G
NG_008332.2:g.34650A>G
NM_000212.3:c.303A>GMANE SELECT
NP_000203.2:p.Gly101=
NP_000203.2:p.Gly101=
LRG_481t1:c.303A>G
LRG_481:g.34650A>G
LRG_481p1:p.Gly101=
NC_000017.10:g.45360857A>G
NM_000212.2:c.303A>G

Molecular consequence:

NM_000212.3:c.303A>G - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: ITGB3-related disorder
Synonyms:: ITGB3-related condition
Identifiers:

Recent activity

Clear Turn Off Turn On

Functional Laterality
Functional Laterality
Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of th...<br/>Year introduced: 2007(1966)

MeSH
Filaricides [Pharmacological Action]
Filaricides [Pharmacological Action]

MeSH
HEXB hexosaminidase subunit beta [Sus scrofa]
HEXB hexosaminidase subunit beta [Sus scrofa]
Gene ID:396958

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004735451	PreventionGenetics, part of Exact Sciences	no assertion criteria provided	Likely benign (May 26, 2023)	germline	clinical testing

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004735451

PreventionGenetics, part of Exact Sciences

no assertion criteria provided

Likely benign
(May 26, 2023)

germline

clinical testing

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004735451.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 13, 2024

ClinVar

Relating variation to medicine